CIK 0000105770
WST WEST PHARMACEUTICAL SERVICES INC
Insider trading from SEC Form 4. Last filing Oct 31, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
1
with a Form 4 at this company
Signals
Open-market buys and sells at WEST PHARMACEUTICAL SERVICES INC, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Congressional trades
3 trades in WST disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Robert P. Bresnahan, Jr. House · R-PA | Sale | WST West Pharmaceutical Services, Inc. Common Stock | $1,001 to $15k | Apr 8, 2025 | 30 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | WST West Pharmaceutical Services, Inc. Common Stock | $1,001 to $15k | Feb 25, 2025 | 30 days after the trade |
| Jared Moskowitz House · D-FL | Sale | WST West Pharmaceutical Services, Inc. Common Stock | $1,001 to $15k | Feb 13, 2025 | 21 days after the trade |
Transactions
The last 3 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 29, 2024 | Abraham Silji SVP, Chief Technology Officer | MOption exercise Common Stock | +458 | $0.00 | $0 | 3,318 | Oct 31, 2024 |
| Oct 29, 2024 | Abraham Silji SVP, Chief Technology Officer | FTax withholding Common Stock | -180 | $318.41 | $57k | 3,138 | Oct 31, 2024 |
| Oct 29, 2024 | Abraham Silji SVP, Chief Technology Officer | MOption exercise Rst. Stock Unitderivative | -458 | $0.00 | $0 | 0 | Oct 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.